2023 NF CONFERENCE - Bundesverband Neurofibromatose e.V.
Two drugs that target one specific mutant allele, KRAS G12C, have already been approved for treating non-small cell lung cancer, and many more are in clinical ...Télécharger 2023 NF CONFERENCE - Bundesverband Neurofibromatose e.V. pdf
